Long-term Study of SYR-472

PHASE3CompletedINTERVENTIONAL
Enrollment

680

Participants

Timeline

Start Date

September 1, 2011

Primary Completion Date

June 1, 2013

Study Completion Date

June 1, 2013

Conditions
Diabetes Mellitus
Interventions
DRUG

SYR-472

oral, for up to 52 weeks.

Trial Locations (41)

Unknown

Akita

Kisarazu-shi

Fukuoka

Munakata-shi

Koriyama-shi

Gihu-shi

Fukuyama-shi

Hiroshima

Eniwa-shi

Ishikari-shi

Nakagawa-gun

Obihiro-shi

Sapporo

Kobe

Mito

Naka

Takamatsu

Sagamihara-shi

Yokohama

Kumamoto

Tamana-shi

Kyoto

Nagano

Nagawaki-shi

Ōita

Minoh

Osaka

Sakai-shi

Ageo-shi

Kawaguchi-shi

Koshigaya-shi

Kuki-shi

Saitama-shi

Suntou-gun

Oyama-shi

Chuo-ku

Koganei-shi

Meguro-ku

Shibuya-ku

Tama-shi

Tiyoda-ku

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY